TXMD Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of TherapeuticsMD, Inc. Is Fair to Shareholders
businesswire.com
news
2022-05-31 00:00:00

May 31, 2022 10:09 AM Eastern Daylight Time NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of TherapeuticsMD, Inc. (NASDAQ: TXMD) to an affiliate of EW Healthcare Partners for $10.00 per share is fair to TherapeuticsMD shareholders.

Halper Sadeh encourages TherapeuticsMD shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.
